Mechanism of Action of Voltage-gated K+ Channel Antibodies in Acquired Neuromyotonia
Overview
Authors
Affiliations
Acquired neuromyotonia (ANM) is associated with antibodies to voltage-gated K+ channels (VGKCs). ANM sera reduce the number of K+ currents in neuronal cell lines, but it is not clear how the antibodies act. Here, we show by using the NB-1 cell line that the reduction in K+ currents by IgG is independent of added complement. IgG Fc and Fab fragments from ANM sera had no effect, but three of four ANM F(ab')2 fragments significantly reduced K+ currents. Thus, cross-linking of the channels by divalent antibodies is likely to be an important mechanism in reducing K+ currents.
Ion channels as therapeutic antibody targets.
Hutchings C, Colussi P, Clark T MAbs. 2018; 11(2):265-296.
PMID: 30526315 PMC: 6380435. DOI: 10.1080/19420862.2018.1548232.
Balint B, Vincent A, Meinck H, Irani S, Bhatia K Brain. 2017; 141(1):13-36.
PMID: 29053777 PMC: 5888977. DOI: 10.1093/brain/awx189.
Sun H, Luo L, Lal B, Ma X, Chen L, Hann C Nat Commun. 2016; 7:10339.
PMID: 26842342 PMC: 4742836. DOI: 10.1038/ncomms10339.
Kim J Korean J Pediatr. 2014; 57(1):1-18.
PMID: 24578711 PMC: 3935107. DOI: 10.3345/kjp.2014.57.1.1.
Antibody therapeutics targeting ion channels: are we there yet?.
Sun H, Li M Acta Pharmacol Sin. 2013; 34(2):199-204.
PMID: 23381110 PMC: 4011603. DOI: 10.1038/aps.2012.202.